Twist Bioscience Corporation - stock earnings
TWST Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 AfterMarket | - / -0.8321000000 | - | - / 72.1 million | - |
TWST Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -43.0 million USD | 71.5 million USD |
| 2023Q3 | -46.2 million USD | 66.9 million USD |
| 2023Q2 | -57.4 million USD | 63.7 million USD |
| 2023Q1 | -59.2 million USD | 60.2 million USD |
| 2022Q4 | -41.8 million USD | 54.2 million USD |
| 2022Q3 | -51.1 million USD | 57.3 million USD |
| 2022Q2 | -60.5 million USD | 56.1 million USD |
| 2022Q1 | -60.7 million USD | 48.1 million USD |
| 2021Q4 | -45.6 million USD | 42.0 million USD |
| 2021Q3 | -41.2 million USD | 38.0 million USD |
| 2021Q2 | -40.0 million USD | 35.0 million USD |
| 2021Q1 | -37.9 million USD | 31.2 million USD |
| 2020Q4 | -32.9 million USD | 28.2 million USD |
| 2020Q3 | -24.3 million USD | 32.4 million USD |
| 2020Q2 | -28.2 million USD | 21.2 million USD |
| 2020Q1 | -31.8 million USD | 19.3 million USD |
| 2019Q4 | -55.6 million USD | 17.2 million USD |
| 2019Q3 | -31.2 million USD | 15.7 million USD |
| 2019Q2 | -27.9 million USD | 13.6 million USD |
| 2019Q1 | -25.9 million USD | 13.6 million USD |
| 2018Q4 | -22.6 million USD | 11.5 million USD |
| 2018Q3 | -19.8 million USD | 8.4 million USD |
| 2018Q2 | -17.6 million USD | 6.5 million USD |
| 2018Q1 | -16.9 million USD | 6.2 million USD |
| 2017Q4 | -16.9 million USD | 4.3 million USD |
| 2017Q3 | -17.0 million USD | 3.5 million USD |
| 2017Q2 | -14.3 million USD | 3.2 million USD |
| 2017Q1 | ? USD | 2.4 million USD |
| 2016Q4 | ? USD | 1.7 million USD |
| 2016Q3 | -44.1 million USD | 2.3 million USD |
TWST Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -204.6 million USD | 245.1 million USD |
| 2022 | -217.9 million USD | 203.6 million USD |
| 2021 | -152.1 million USD | 132.3 million USD |
| 2020 | -139.9 million USD | 90.1 million USD |
| 2019 | -107.7 million USD | 54.4 million USD |
| 2018 | -71.2 million USD | 25.4 million USD |
| 2017 | -59.3 million USD | 10.8 million USD |
| 2016 | -44.1 million USD | 2.3 million USD |
TWST
Price: $31.96
52 week price:
Earnings Per Share: -3.61 USD
P/E Ratio: -9.57
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 1.1 million
Market Capitalization: 1.9 billion